News articles about Cardinal Health (NYSE:CAH) have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardinal Health earned a news sentiment score of 0.17 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.5029251306857 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the headlines that may have impacted Accern Sentiment’s rankings:
- ETFs with exposure to Cardinal Health, Inc. : December 5, 2017 (finance.yahoo.com)
- Cardinal Health (CAH) Coverage Initiated at Deutsche Bank (americanbankingnews.com)
- Amazon Pharma Business Rumors Are Making Drug Stocks Go Crazy (finance.yahoo.com)
- Interesting CAH Put And Call Options For January 2018 (nasdaq.com)
- Stock’s Technical Analysis: Cardinal Health Inc (NYSE: CAH) – Alpha Beta Stock (alphabetastock.com)
Several brokerages have commented on CAH. Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a research note on Monday, August 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cardinal Health in a research note on Thursday, October 12th. Cowen upgraded shares of Cardinal Health to a “buy” rating and set a $74.00 price target on the stock in a research note on Tuesday, October 10th. Mizuho set a $70.00 price target on shares of Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, October 24th. Finally, Jefferies Group set a $77.00 price target on shares of Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, August 29th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $73.91.
Cardinal Health (NYSE:CAH) last announced its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period last year, the firm posted $1.24 earnings per share. analysts expect that Cardinal Health will post 4.97 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.06%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.94%.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
What are top analysts saying about Cardinal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardinal Health Inc. and related companies.